Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature

被引:13
|
作者
Reynaert, Hendrik [1 ,2 ]
Colle, Isabelle [3 ,4 ]
机构
[1] UZBrussel, Dept Gastroenterol Hepatol, Laarbeeklaan 101, B-1090 Brussels, Belgium
[2] Vrije Univ Brussel, Liver Cell Biol Lab, Laarbeeklaan 103, B-1090 Brussels, Belgium
[3] ASZ Aalst, Dept Gastroenterol Hepatol, Merestr 80, B-9300 Aalst, Belgium
[4] Univ Ghent, Dept Gastroenterol Hepatol, Pintelaan, B-9000 Ghent, Belgium
关键词
hepatocellular carcinoma; octreotide; somatostatin; somatostatin analogues; somatostatin receptor; LONG-ACTING OCTREOTIDE; RECEPTOR SUBTYPES; PLUS OCTREOTIDE; PLACEBO; MULTICENTER; EXPRESSION; TUMOR; PROLIFERATION; PASIREOTIDE; SORAFENIB;
D O I
10.3390/ijms20194811
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma, one of the most dreaded complications of cirrhosis, is a frequent cancer with high mortality. Early primary liver cancer can be treated by surgery or ablation techniques, but advanced hepatocellular carcinoma remains a challenge for clinicians. Most of these patients have underlying cirrhosis, which complicates or even precludes treatment. Therefore, efficacious treatments without major side effects are welcomed. Initial results of treatment of advanced hepatocellular carcinoma with somatostatin analogues were promising, but subsequent trials have resulted in conflicting outcomes. This might be explained by different patient populations, differences in dosage and type of treatment and differences in somatostatin receptor expression in the tumor or surrounding tissue. It has been shown that the expression of somatostatin receptors in the tumor might be of importance to select patients who could benefit from treatment with somatostatin analogues. Moreover, somatostatin receptor expression in hepatocellular carcinoma has been shown to correlate with recurrence, prognosis, and survival. In this review, we will summarize the available data on treatment of primary liver cancer with somatostatin analogues and analyze the current knowledge of somatostatin receptor expression in hepatocellular carcinoma and its possible clinical impact.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Current perspectives on the pharmacological treatment of advanced hepatocellular carcinoma: a narrative review
    Yoo, Hye-Jin
    Yoo, Jeong -Ju
    Kim, Gyune
    Kim, Seok
    EWHA MEDICAL JOURNAL, 2024, 47 (04):
  • [32] Rupture of Hepatocellular Carcinoma: A Review of Literature
    Sahu, Srimanta K.
    Chawla, Yogesh K.
    Dhiman, Radha K.
    Singh, Virendra
    Duseja, Ajay
    Taneja, Sunil
    Kalra, Naveen
    Gorsi, Ujjwal
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (02) : 245 - 256
  • [33] Lenvatinib for Hepatocellular Carcinoma: A Literature Review
    Hatanaka, Takeshi
    Naganuma, Atsushi
    Kakizaki, Satoru
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 20
  • [34] Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
    Rathi, Nityam
    Maughan, Benjamin L.
    Agarwal, Neeraj
    Swami, Umang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3741 - 3749
  • [35] Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives
    Girardi, Daniel M.
    Pacifico, Jana Priscila M.
    Guedes de Amorim, Fernanda P. L.
    dos Santos Fernandes, Gustavo
    Teixeira, Marcela C.
    Pereira, Allan A. L.
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 21
  • [36] Transcatheter arterial procedures in the treatment of patients with hepatocellular carcinoma: a review of literature
    De Maio, E
    Fiore, F
    Daniele, B
    D'Angelo, R
    Perrone, F
    Barletta, E
    Iaffaioli, RV
    Pignata, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 46 (03) : 285 - 295
  • [37] Systemic Treatment for Advanced Hepatocellular Carcinoma
    Bouattour, Mohamed
    Mehta, Neil
    He, Aiwu R.
    Cohen, Emil, I
    Nault, Jean-Charles
    LIVER CANCER, 2019, 8 (05) : 341 - 358
  • [38] Antineoplaston treatment for advanced hepatocellular carcinoma
    Kumabe, T
    Tsuda, H
    Uchida, M
    Ogoh, Y
    Hayabuchi, N
    Sata, M
    Nakashima, O
    Hara, H
    ONCOLOGY REPORTS, 1998, 5 (06) : 1363 - 1367
  • [39] Treatment of Large and Advanced Hepatocellular Carcinoma
    Eddie K. Abdalla
    Alban Denys
    Kiyoshi Hasegawa
    Thomas W. T. Leung
    Masatoshi Makuuchi
    Ravi Murthy
    Dario Ribero
    Daria Zorzi
    Jean-Nicolas Vauthey
    Guido Torzilli
    Annals of Surgical Oncology, 2008, 15 : 979 - 985
  • [40] Precision treatment in advanced hepatocellular carcinoma
    Yang, Xupeng
    Yang, Chen
    Zhang, Shu
    Zhu, Andrew X.
    Geng, Haigang
    Bernards, Rene
    Qin, Wenxin
    Fan, Jia
    Wang, Cun
    Gao, Qiang
    CANCER CELL, 2024, 42 (02) : 180 - 197